Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 10.94
+0.19 (1.77%)
Oct 23, 2026, 3:04 PM CST
| Market Cap | 4.57B -16.6% |
| Revenue (ttm) | 466.05M +6.2% |
| Net Income | 46.50M +11.8% |
| EPS | 0.11 +17.4% |
| Shares Out | 417.60M |
| PE Ratio | 98.77 |
| Forward PE | n/a |
| Dividend | 0.06 (0.55%) |
| Ex-Dividend Date | Jun 12, 2026 |
| Volume | 8,808,482 |
| Open | 12.00 |
| Previous Close | 10.75 |
| Day's Range | 10.20 - 12.00 |
| 52-Week Range | 9.01 - 16.95 |
| Beta | 0.54 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |